Pharmaceutical News BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
[ logo.jpg]BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial wit
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc™ (micon
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
It seems some pharmaceutical and medical device companies are promising that they will soon voluntarily start making public the grants and monies they provide to doctors and nonprofit organizations for things such as conferences and continuing educa
read more »
Add this link to...
Bury
Add to:
| Bookmarks
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial wit)